Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

159 Results
Title Activity Code Posting Date Sort ascending Expiration Date
Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 R01 June 27, 2022 December 08, 2022
Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 U24 June 14, 2022 September 16, 2022
Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 U24 June 06, 2022 August 26, 2022
Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 U2C June 06, 2022 August 11, 2022
Notice of Special Interest (NOSI)— Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42 Clinical Trial Optional)- NOT-ES-22-009 R41/R42 June 03, 2022 April 06, 2023
Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44 Clinical Trial Optional)- NOT-ES-22-010 R43/R44 June 03, 2022 April 06, 2023
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-22-176 R43/R44 June 02, 2022 April 06, 2023
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-22-178 R41/R42 June 02, 2022 April 06, 2023
Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 Multiple June 01, 2022 May 08, 2025
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)- PAR-22-185 X01 May 27, 2022 January 18, 2025
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 P01 May 27, 2022 October 14, 2022
Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 Supp May 20, 2022 July 06, 2022
Transgender People—Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)- PAR-22-186 R21 May 19, 2022 December 08, 2024
Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 R01 May 12, 2022 September 13, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 R01 May 10, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 R21 May 10, 2022 May 08, 2025
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 R01 May 10, 2022 September 15, 2022
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy- NOT-CA-22-063 Multiple May 03, 2022 July 05, 2024
Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 R01 April 29, 2022 May 08, 2025
Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 R01, R41/R42, R21, R43/R44 April 29, 2022 May 08, 2025
Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 UG3/UH3 April 13, 2022 August 04, 2022
Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)- RFA-OD-22-008 R03 April 08, 2022 July 02, 2024
Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 Supp April 06, 2022 October 18, 2024
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 R01 April 05, 2022 July 30, 2022
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)- RFA-OD-22-009 R01 April 05, 2022 July 02, 2024